Standout Papers
Citation Impact
Citing Papers
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Laparoscopic Roux-en-Y Gastric Bypass versus Sleeve Gastrectomy for Obese Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
2015
Psychiatric Diagnoses and Psychiatric Treatment Among Bariatric Surgery Candidates
2004
Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome
2005
Nonalcoholic steatohepatitis
1996
Standardized outcomes reporting in metabolic and bariatric surgery
2015 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Thiazolidinediones
2004 Standout
Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study
1999
Bone Turnover and Insulin-like Growth Factor I Levels Increase After Improved Glycemic Control in Noninsulin-dependent Diabetes Mellitus
1998
Twenty Years of Biliopancreatic Diversion: What is the Goal of the Surgery?
2004
Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
2002
Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes
2009
Nonalcoholic fatty liver disease
2002
Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery
2005
Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in Mice
2008
Does obesity surgery improve psychosocial functioning? A systematic review
2003
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Bariatric Surgery
2004 Standout
Psychosocial and Behavioral Aspects of Bariatric Surgery
2005
Nonalcoholic Fatty Liver Disease
2002 Standout
Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus
2013
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Effects of Obesity Surgery on the Metabolic Syndrome
2004
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
2001
Initial Management of Glycemia in Type 2 Diabetes Mellitus
2002
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus
1997
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
2014 Nature
Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
2000 Standout
Epidemiology of Non-Alcoholic Fatty Liver Disease
2010
Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial
2012
National Trends in Utilization and In-Hospital Outcomes of Bariatric Surgery
2002
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity
2013
Apolipoprotein synthesis in nonalcoholic steatohepatitis
2002
Metabolic Aspects of Bariatric Surgery
2007
INTENSIVE THERAPIES FOR PEDIATRIC OBESITY
2001
Obesity and the Risk for Cardiovascular Disease
2003
Conversion of biomass to selected chemical products
2011 Standout
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
2009 Standout
Vertical Banded Gastroplasty Versus Standard or Distal Roux-en-Y Gastric Bypass Based on Specific Selection Criteria in the Morbidly Obese: Preliminary Results
1999
Obesity
2005 Standout
CHEMICAL MODIFICATION OF STARCH
2004
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes
2006
Liver fibrosis in overweight patients
2000
Pharmacological and surgical treatments for obesity
2006
The metabolic syndrome
2005 Standout
Laparoscopic Gastric Bypass, Roux en-Y - 500 Patients: Technique and Results, with 3-60 month follow-up
2000 Standout
Current status of medical and surgical therapy for obesity
2001
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Biliopancreatic Diversion with a Duodenal Switch
1998
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
Diabetes and Hypertension in Severe Obesity and Effects of Gastric Bypass-Induced Weight Loss
2003
Evolution of Operative Procedures for the Management of Morbid Obesity 1950-2000
2002
The Impact of Weight Reduction Surgery on Health-Care Costs in Morbidly Obese Patients
2004
A New Paradigm for Type 2 Diabetes Mellitus
1998
Clinical Management After Bariatric Surgery: Value of a Multidisciplinary Approach
2006
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass
2005
Impact of gastric bypass operation on survival: A population-based analysis
2004
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
2017
Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus
2003
Impact of Obesity and Bariatric Surgery on Cardiovascular Disease
2007
The surgical treatment of morbid obesity
1998
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Prospective Evaluation of Unexplained Chronic Liver Transaminase Abnormalities in Asymptomatic and Symptomatic Patients
1999
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Gastric Bypass vs Sleeve Gastrectomy for Type 2 Diabetes Mellitus
2011
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Type 2 Diabetes and Weight Loss following Biliopancreatic Diversion for Obesity
2006
Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
2015
Lessons from the Swedish Obese Subjects Study: The effects of surgically induced weight loss on obesity comorbidity
2005
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
2008
Is Intestinal Gluconeogenesis a Key Factor in the Early Changes in Glucose Homeostasis Following Gastric Bypass?
2011
Long-term Pharmacotherapy of Obesity 2000
2001
Medical and surgical options in the treatment of severe obesity
2002
Nonalcoholic fatty liver disease
2005 Standout
A comparison study of laparoscopic versus open gastric bypass for morbid obesity1
2000
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
2016
Two‐Year Changes in L ipids and Lipoproteins Associated with the Maintenance of a 5 % to 10% Reduction in Initial Weight: Some Findings and Some Questions
1999
Potential of Surgery for Curing Type 2 Diabetes Mellitus
2002
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
2003
Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid (Grade 3) Obesity and its Metabolic Complications: A Three-Year Study
2002
AGA technical review on obesity
2002
Hepatocellular Carcinoma
2011 Standout
Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes
2003
Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients
2004 Standout
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Improvements in insulin sensitivity and β‐cell function (HOMA) with weight loss in the severely obese
2003
VERTICAL BANDED GASTROPLASTY
2001
Bariatric surgery: an IDF statement for obese Type 2 diabetes
2011
Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery
2003
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Etiology of Type II Diabetes Mellitus: Role of the Foregut
2001
Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force
2003
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Bariatric surgery: an IDF statement for obese Type 2 diabetes
2011
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Changes in Diabetic Management After Roux-en-Y Gastric Bypass
1996
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Laparoscopic Versus Open Gastric Bypass: A Randomized Study of Outcomes, Quality of Life, and Costs
2001 Standout
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity
2018 Standout
Significant Changes in Blood Pressure, Glucose, and Lipids with Gastric Bypass Surgery
1998
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.
2006
A Bariatric Surgery Algorithm
2002
Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program
2006
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
2011
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
1997
Effect of Serotonin on Glycogen Metabolism in Isolated Rat Liver*
1964
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding
2002
Laparoscopic Adjustable Gastric Banding
1998
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease
2007
Weight loss maintenance.
2010
Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension
2000
Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents
2000
The Metabolic Syndrome
2008 Standout
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity
2005
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity
2012
Nonalcoholic Fatty Liver Disease
2015 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2006
Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
2016
Works of Stuart Long being referenced
Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus
1995 Standout
Circulating Insulin-Like Growth Factor I Concentrations in Clinically Severe Obese Patients With and Without NIDDM in Response to Weight Loss
1994
Enteric Coatings II**Product Research and Development Dept., The Upjohn Co., Kalamazoo, Mich.
1959
Coronary Heart Disease Risk Factors in Morbidly Obese Women With Normal Glucose Tolerance
1993
Liver pathology in morbidly obese patients with and without diabetes.
1990
Some Physiologic Responses to 5-Hydroxytryptamine Creatinine Sulfate
1952